KRAS and pancreatic neoplasm: Several statins, comprising natural ones (lovastatin and simvastatin), efficiently inhibited KRas protein trafficking from the cytoplasm to the cell membrane of pancreatic cancer cells due to depletion of the mevalonate pathway intermediates [180].